| Zopiclone | |
|---|---|
| Salts [] | |
|---|---|
| Zopiclone hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 388.8 g/mol [1] |
| Melting point | 178 °C [1] |
| Solubility | >58.3 [ug/mL] (The mean of the results at pH 7.4) [1] |
| Predicted LogP | 0.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H17ClN6O3 [1] |
| IUPAC name | [6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate [1] |
| SMILES | CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl [1] |
| InChI | InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3 [1] |
| InChIKey | GBBSUAFBMRNDJC-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | ~5 hours (3.5 – 6.5 hours) ~7 – 9 hours for 65+ years old |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - oral: 827 mg/kg - intraperitoneal: 771 mg/kg - subcutaneous: 540 mg/kg - intravenous: 280 mg/kg - intramuscular: 295 mg/kg Mouse: - oral: 2174 mg/kg - intraperitoneal: 1325 mg/kg - subcutaneous: 888 mg/kg - intravenous: 321 mg/kg - intramuscular: 541 mg/kg |
| Dosing[] |
|---|
| Sublingual [] | |
|---|---|
| Light | ≤ 6.8 mg |
| Common | 6.8 - 8.8 mg |
| Strong | 8.8 - 10 mg |
| Heavy | 10 - 14.7 mg |
| Extreme | 14.7 mg + |
| Oral [] | |
|---|---|
| Light | ≤ 13.2 mg |
| Common | 13.2 - 20 mg |
| Strong | 20 - 22.5 mg |
| Heavy | 22.5 - 30 mg |
| Extreme | 30 mg + |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Zopiclone
Zopiclone (also known as Imovane, Zimovane, Amoban, Zopiclona, Zopiclonum, Ximovan, RP-27267, RP 27267, [6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate or Zimovane LS) is a
Chemistry
Salts []
Zopiclone is typically found in the form of its hydrochloride salt.
Stereochemistry []
Zopiclone is a racemic mixture of the enantiomers
| Stereoisomers |
|---|
| Anodyne Usernotes [] | |
|---|---|
| magnus / Zopiclone via Oral |
|
Legal status
- Australia: Zopiclone is a S4 substance.
- Brazil: Zopiclone is a B1 substance.[3]
- Canada: Zopiclone is a prescription only substance.
- United Kingdom: Zopiclone is a Class C substance.
- New Zealand: Zopiclone is a Class C substance.
- United States: Zopiclone is a Schedule I under the "Controlled Substances Act (CSA)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5735, Zopiclone. Accessed October 14, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/5735
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Zopiclone. UNII: 03A5ORL08Q. Global Substance Registration System. Accessed October 14, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/03A5ORL08Q
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed October 14, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Anodyne